Not exact matches
Overweight and obese MGUS patients had a 55 percent and 98 percent higher risk of
progression to multiple
myeloma, respectively, than normal - weight MGUS patients.
«Based on our finding that being overweight or obese is a risk factor for multiple
myeloma in MGUS patients, and since extra weight is a modifiable risk factor, we hope that our results will encourage intervention strategies to prevent the
progression of this condition to multiple
myeloma as soon as MGUS is diagnosed,» Chang said.
African - American men also were more likely than their Caucasian counterparts to experience a
progression from MGUS to multiple
myeloma.
«For patients diagnosed with MGUS, maintaining a healthy weight may be a way to prevent the
progression to multiple
myeloma, if further confirmed by clinical trials.»
The authors speculate the reasons for the prolonged survival in their study is that patients with MGUS are evaluated more often for signs of
progression to MM and may be diagnosed and started on therapy for
myeloma at an earlier stage.
If we can find ways to block the
progression of MGUS, we hope to prevent many cases of
myeloma in the future.»
The laboratory is interested in mechanisms by which interactions between neutrophils and multiple
myeloma cells promote disease
progression and chemoresistance.
No Association Between Response Rates and Survival in Newly Diagnosed Multiple
Myeloma: Results of a recent meta - regression analysis of 63 randomized clinical trials out of Greece concluded that there was no association between conventional response outcomes, such as complete response (CR) or very good partial response (VGPR), and overall (OS) or progression - free survival (PFS) in patients with newly diagnosed multiple myeloma in populations of patients who received stem cell transplant and those who d
Myeloma: Results of a recent meta - regression analysis of 63 randomized clinical trials out of Greece concluded that there was no association between conventional response outcomes, such as complete response (CR) or very good partial response (VGPR), and overall (OS) or
progression - free survival (PFS) in patients with newly diagnosed multiple
myeloma in populations of patients who received stem cell transplant and those who d
myeloma in populations of patients who received stem cell transplant and those who did not.
Inspired by XBP - 1's roles in maintaining a homeostatic ER, the lab began to examine the role of XBP - 1 in B - cell leukemia whose
progression does not require dramatic ER expansion like that in multiple
myeloma.
Which plant and animal foods are associated with the development of multiple
myeloma, and what effect might the spice turmeric have on the
progression of monoclonal gammopathy of undetermined significance?
Progression of an extramedullary plasmacytoma to multiple
myeloma in a cat.